Matches in Nanopublications for { ?s ?p "[The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP552254.RA00K6pj6nUpuJoQqXxKW2HgxV4mQNa_W3ahQwqXxkcFU130_assertion description "[The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552254.RA00K6pj6nUpuJoQqXxKW2HgxV4mQNa_W3ahQwqXxkcFU130_provenance.
- assertion description "[The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP341648.RAqpKQzmJHnBnFM2DH0MyqTuQfE0e3nwXgl2ow1dE2uf4130_assertion description "[The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341648.RAqpKQzmJHnBnFM2DH0MyqTuQfE0e3nwXgl2ow1dE2uf4130_provenance.
- NP1053323.RA6NHA_08fpGoxE7dXhRkeNKqJ0r73GAfNBW_ASjWLTg8130_assertion description "[The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053323.RA6NHA_08fpGoxE7dXhRkeNKqJ0r73GAfNBW_ASjWLTg8130_provenance.